Results 91 to 100 of about 6,254 (213)

Effects of autoantibodies removed by immunoadsorption from patients with dilated cardiomyopathy on neonatal rat cardiomyocytes

open access: yes, 2006
INTRODUCTION: Immunoadsorption has been shown to improve cardiac performance and reduce mortality in patients with dilated cardiomyopathy. In this study, the underlying mechanism for these beneficial effects was investigated in cultured rat ...
Fedorkova, O.,   +6 more
core   +1 more source

Immunoadsorption in patients with neuromyelitis optica spectrum disorder. [PDF]

open access: yes, 2016
INTRODUCTION Neuromyelitis optica spectrum disorder (NMOSD) is a neuroinflammatory disorder of the central nervous system, distinct from multiple sclerosis by affecting predominantly the optic nerve and the spinal cord, and mediated by antibodies ...
Yoon, Min-Suk   +11 more
core   +1 more source

Successful and well-tolerated bi-weekly immunoadsorption regimen in pemphigus vulgaris

open access: yes, 2017
BACKGROUND: Pemphigus vulgaris is a chronic autoimmune disease characterized by blisters and erosions forming in the mucous membranes and the skin. Many patients are severely impaired by pain, weight loss and increased risk of infections.
Jenny Dietze   +13 more
core   +1 more source

Exploring the nursing characteristics and management for patients with high levels of human leukocyte antigen (HLA) - antibodies undergoing different desensitization strategies before allogeneic hematopoietic stem cell transplantation (allo-HSCT)

open access: yesZhongguo shuxue zazhi
[Objective] To investigate the efficacy, nursing characteristics, and management of different desensitization strategies before allogeneic hematopoietic stem cell transplantation (allo-HSCT) among patients with high level of human leukocyte antigen (HLA)
ZHOU Danping   +6 more
doaj   +1 more source

Immunotherapies in Rasmussen’s Encephalitis

open access: yesPediatric Neurology Briefs, 2004
Corticosteroids, IV immunoglobulins (IVIg), cyclophosphamide, therapeutic plasma exchange (TPE), and protein A IgG immunoadsorption (PAI) were evaluated in 15 patients with confirmed Rasmussen’s encephalitis (RE) and reported from various centers in ...
J Gordon Millichap
doaj   +1 more source

Immunoadsorption (IAS) for systemic lupus erythematosus

open access: yes, 2011
Immunoadsorption (IAS) is used as a rescue therapy in severely ill SLE patients who are refractory to conventional therapies. This extracorporeal method aims at the rapid and extensive removal of pathogenic immunocomplexes (ICs) and (auto-)antibodies ...
GH Stummvoll
core   +1 more source

Protein A tangential flow affinity membrane cartridge for extracorporeal immunoadsorption therapy

open access: yes, 1999
Tangential flow affinity membrane cartridge (TFAMC) fs a new model of immunoadsorption therapy for hemoperfusion. Recombinant Protein A was immobilized on the membrane cartridge through Schiff base formation for extracorporeal IgG and immune complex ...
Jia, JY   +13 more
core   +1 more source

immunoadsorption

open access: yes
Citation: 'immunoadsorption' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.13275 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms.
openaire   +1 more source

Staphylococcyl Protein A Immunoadsorption: Its Use, Effect, And Proposed Mechanisms Of Action [PDF]

open access: yes, 1989
Four patients, two with Idiopathic Thrombocytopenic Purpura, one with advanced Astrocytoma, and one with Systemic Lupus Neutropenia, were treated with the Prosorba® Immunoadsorption Column on an out-patient basis.
Stein, Edward
core  

Adjuvant treatment of recalcitrant Bullous pemphigoid with immunoadsorption

open access: yes, 2012
Elimination of pathogenic autoantibodies by immunoadsorption (IA) has been described as an effective adjuvant treatment in severe bullous autoimmune diseases, especially in pemphigus.
Klinker, E.   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy